QCM
TMO icon

Quantinno Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Quantinno Capital Management’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$92.5M Buy
188,243
+19,597
+12% +$10.6M 0.15% 98
2025
Q4 		$97.7M Buy
168,646
+33,621
+25% +$19M 0.2% 71
2025
Q3 		$65.5M Buy
135,025
+50,341
+59% +$23.4M 0.18% 76
2025
Q2 		$34.3M Sell
84,684
-2,361
-3% -$987K 0.15% 109
2025
Q1 		$43.3M Buy
87,045
+21,843
+34% +$11.8M 0.28% 41
2024
Q4 		$33.9M Buy
65,202
+2,228
+4% +$1.22M 0.33% 35
2024
Q3 		$39M Buy
62,974
+7,568
+14% +$4.48M 0.51% 24
2024
Q2 		$30.6M Buy
55,406
+1,490
+3% +$854K 0.55% 23
2024
Q1 		$31.3M Buy
53,916
+31,779
+144% +$17.8M 0.68% 13
2023
Q4 		$11.8M Buy
22,137
+842
+4% +$408K 0.41% 29
2023
Q3 		$10.8M Buy
21,295
+5,779
+37% +$3.08M 0.49% 27
2023
Q2 		$8.1M Sell
15,516
-1,134
-7% -$612K 0.46% 30
2023
Q1 		$9.6M Buy
16,650
+779
+5% +$439K 0.63% 16
2022
Q4 		$8.74M Buy
15,871
+2,010
+15% +$1.07M 0.65% 16
2022
Q3 		$7.03M Sell
13,861
-96
-0.7% -$53.7K 0.91% 10
2022
Q2 		$7.58M Sell
13,957
-73
-0.5% -$40.2K 1.09% 8
2022
Q1 		$8.29M Sell
14,030
-3,375
-19% -$1.94M 1.26% 5
2021
Q4 		$11.6M Buy
17,405
+16,470
+1,761% +$10.3M 2.1% 4
2021
Q3 		$534K Buy
935
+31
+3% +$17K 0.6% 46
2021
Q2 		$456K Hold
904
– – 0.52% 69
2021
Q1 		$413K Sell
904
-253
-22% -$121K 0.45% 90
2020
Q4 		$539K Buy
1,157
+253
+28% +$119K 0.42% 61
2020
Q3 		$399K Hold
904
– – 0.27% 182
2020
Q2 		$328K Hold
904
– – 0.32% 135
2020
Q1 		$256K Sell
904
-329
-27% -$104K 0.16% 302
2019
Q4 		$401K Sell
1,233
-251
-17% -$76.1K 0.25% 163
2019
Q3 		$432K Sell
1,484
-627
-30% -$180K 0.29% 140
2019
Q2 		$620K Hold
2,111
– – 0.36% 54
2019
Q1 		$578K Sell
2,111
-1,139
-35% -$283K 0.37% 77
2018
Q4 		$727K Buy
+3,250
New +$763K 0.59% 9

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Quantinno Capital Management's TMO Position: Q1 2026 in Review

Quantinno Capital Management increased its Thermo Fisher Scientific (TMO) stake by 12% in Q1 2026, buying an estimated $10.6M and bringing the position to 188,243 shares worth $92.5M. The position accounts for 0.15% of the portfolio, ranked #98.

Quantinno Capital Management first reported a position in TMO in Q4 2018 and has held it in 30 quarters since. The position peaked at $97.7M in Q4 2025. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Quantinno Capital Management held 188,243 shares of Thermo Fisher Scientific worth $92.5M as of Q1 2026.
  • Quantinno Capital Management bought 19,597 Thermo Fisher Scientific shares in Q1 2026, an estimated $10.6M.
  • Thermo Fisher Scientific made up 0.15% of Quantinno Capital Management's portfolio in Q1 2026, its #98 holding.
  • Quantinno Capital Management first reported a position in Thermo Fisher Scientific in Q4 2018 and has held it in 30 quarters since.
  • Quantinno Capital Management's Thermo Fisher Scientific position peaked at $97.7M in Q4 2025.
  • 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Quantinno Capital Management's 13F filing for Q1 2026, filed 15 May 2026.